Spirovant

Spirovant Sciences is a biotechnology company and a leader in the development of gene therapies for cystic fibrosis (CF) and other pulmonary diseases. Spirovant is pioneering the treatment of inherited lung diseases, focusing on altering the course of cystic fibrosis and other pulmonary conditions. Their gene therapy technology aims to overcome historical barriers that have hindered effective gene therapy for cystic fibrosis.